Physician profile
Sunil Arora
NPI 1962583104
$8,178.59
in general payments reported to CMS, 2019-2025
26 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $514 · 2022: $2,917 · 2023: $313 · 2024: $3,157 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,300 · Food and Beverage: $1,350 · Travel and Lodging: $630 · Education: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,300.00 |
| Food and Beverage | $1,350.43 |
| Travel and Lodging | $629.56 |
| Education | $242.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $3,159.23 | 2020-2025 | |
| Actelion Pharmaceuticals US, INC. | $2,989.43 | 2020-2025 | Opsumit, Uptravi |
| Cook Incorporated | $369.54 | 2025 | Blue Rhino |
| Astrazeneca Pharmaceuticals LP | $304.73 | 2019-2025 | Breztri |
| Glaxosmithkline, LLC. | $263.50 | 2019-2024 | Arexvy, Nucala |
| Merck Sharp & Dohme LLC | $194.78 | 2019-2025 | Winrevair, Zerbaxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $185.04 | 2019-2025 | Jascayd |
| United Therapeutics Corporation | $147.82 | 2024 | Tyvaso |
| Inari Medical, INC. | $139.45 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $62.18 | 2019-2025 | Respiratory |
| Genzyme Corporation | $61.00 | 2025 | |
| Amgen INC. | $36.00 | 2025 | Repatha |
| Resmed Corp | $34.78 | 2020-2024 | |
| Advanced Respiratory, INC | $34.62 | 2020 | |
| Pfizer INC. | $26.98 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $17.80 | 2020 | |
| Csl Behring | $16.82 | 2019 | |
| Axsome Therapeutics, INC. | $16.69 | 2023 | Sunosi |
| Teva Pharmaceuticals USA, INC. | $16.67 | 2019 | |
| Genentech USA, INC. | $16.50 | 2020 | |
| Sunovion Pharmaceuticals INC. | $16.36 | 2019 | |
| Mallinckrodt Hospital Products INC. | $15.77 | 2020 | |
| Sanofi Pasteur INC. | $15.11 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.58 | 2020 | |
| Arbor Pharmaceuticals, INC. | $12.51 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.